Monday, January 17, 2022

< + > The Drug Industry Might Have Dodged A Build Back Better Bullet But Remains In Congressional Crosshairs

Industry critics have managed to get a foothold with reforms that will have devastating, long-term effects for patients and drug companies alike. And worse, they were included in a bill that could actually pass via the special reconciliation process that governs federal budgeting.

No comments:

Post a Comment

< + > Bonus Features – September 21, 2025 – 19% of cyberattacks cost healthcare orgs at least $200,000, only 49% of healthcare leaders think AI will solve their cost efficiency problems, plus 26 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...